STOCKS NEWS US-Royal Caribbean down after outlook

Stocks on the move [HOT-RTRS]

Real-time Equity news [U][E][RESF/US]

For U.S. stock market report double-click [.N]
0902 ET 29June2009-Royal Caribbean down after outlook
------------------------------------------------------------------------------

Shares of Royal Caribbean Cruises Ltd (RCL.N) edged lower
in premarket trading on Monday, after the company said that
higher fuel prices and the outbreak of the H1N1 flu virus would
hurt the company's full-year earnings.

It also said its profit would be hurt by foreign currency
adjustments and ineffective hedging. [ID:nN29372910]

Shares slid 1.1 percent to $13.13 in premarket trading
while peer company Carnival Corp (CCL.N) rose 1.4 percent to
$25.71 before the bell.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0852 ET 29June2009-Two firms raised price targets on Microsoft
------------------------------------------------------------------------------

At least two analysts raised their price targets on
Microsoft Corp (MSFT.O) on Monday, ahead of the release of the
software company's Windows 7 product.

Deutsche Bank raised its price target to $30 from $22,
writing that Windows 7 would lend upside to the stock.

The firm wrote that since there were few hardware
requirements for Windows 7, it made software only upgrades more
likely.

"This is significant as it will allow legacy Vista PCs to
be upgraded to Windows 7," Deutsche Bank wrote. "This should
add $500 million to $1 billion in incremental revenue if an
additional 1 percent to 2 percent of the installed base
upgrades to Win 7 without purchasing new PCs."

Collins Stewart also raised its price target on the Dow
component to $30, citing "incremental opportunities" from
Windows 7.

Shares of Microsoft rose 1 percent to $23.59 in premarket
trading.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0847 ET 29June2009-Biogen falls, reports case of brain
infection
------------------------------------------------------------------------------

Shares of Biogen Idec (BIIB.O) fell in premarket trading on
Monday, after the company said a 10th patient taking its
multiple sclerosis drug Tysabri has developed a potentially
deadly brain infection since it was reintroduced to the market
in July 2006.

The Cambridge, Massachusetts-based biotech company released
the news on its website late on Friday.

The drug was temporarily withdrawn from the market in 2005
after it was linked with a brain infection known as progressive
multifocal leukoencephalopathy, or PML. It was brought back in
2006 with stricter safety warnings.

For details, see [ID:nN2980046]

Shares slid 3.6 percent to $48.29 in premarket trading.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0843 ET 29June2009-Northrop JV wins U.S. Army contract
------------------------------------------------------------------------------

British defense electronics company Cobham (COB.L) said on
Monday that its joint venture with Northrop Grumman (NOC.N) had
been awarded a contract to provide battlefield communications
equipment to the U.S. Army.

The ten-year deal to supply its VIS-X system allowing
communication between vehicles on the battlefield is worth up
to $2.4 billion of which Cobham's share will be 50 percent, the
British company said in a statement.

For details, see [ID:nLT605116]

Shares of Northrop closed Friday at $45.96.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0835 ET 29June2009-KBW raises view on credit card companies
------------------------------------------------------------------------------

KBW on Monday raised its price targets on a number of
credit card companies, saying the sector "will continue to
provide one of the most lucrative returns of the asset classes
within banks' portfolios."

The firm added that the lack of growth opportunities in the
industry after the credit cycle could drive merger and
acquisition activity after banks are better capitalized.

KBW lifted its target on Dow component American Express
(AXP.N) to $29 from $18 while Capital One's (COF.N) was raised
to $29 from $21. Discover Financial (DFS.N) was upgraded to
outperform from market perform.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net